IPP Bureau
India Health Link join hands with U GRO Capital
By IPP Bureau - April 20, 2022
U GRO Capital is a listed MSME lending fintech platform
SoftBank Robotics takes a five per cent stake in Avalon SteriTech
By IPP Bureau - April 20, 2022
Strive to empower public health with disinfection robotics solutions in post-pandemic era
Leading inhalation APIs expert Inke to triple production capacity
By IPP Bureau - April 20, 2022
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
PM Modi awards Startups at Global Ayush Summit
By IPP Bureau - April 20, 2022
The main aim of the challenge is to encourage early-stage start-ups and individuals working on innovations in Ayurveda and other alternative healing and medicine systems
Celogics license in NEXEL's Cardiosight-S for global distribution
By IPP Bureau - April 20, 2022
The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development
Plasma-based green disinfectants can limit spread of infectious diseases like Covid-19
By IPP Bureau - April 20, 2022
Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for Covid-19
SNIPR BIOME initiates first-in-human clinical trial with SNIPR001
By IPP Bureau - April 20, 2022
The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut
MicroGEM granted EUA for Covid-19 PCR Saliva test
By IPP Bureau - April 20, 2022
The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes
Bridge Biotherapeutics enters into an exclusive license agreement with Shaperon
By IPP Bureau - April 19, 2022
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
Asahi Kasei Medical to acquire US based CDMO Bionova Scientific
By IPP Bureau - April 19, 2022
Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture
Navidea Biopharmaceuticals gets regulatory approval of Lymphoaim in India
By IPP Bureau - April 19, 2022
Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer
WHO report highlights the role of traditional Chinese medicine in the treatment of Covid-19
By IPP Bureau - April 19, 2022
The report pointed out that in the process of treating Covid-19, there are promising data to suggest that TCM is beneficial in reducing the risk of progression from mild-to-moderate cases to severe Covid-19
Bollywood actor Sonu Sood joins hands with Aster Volunteers to raise awareness on liver disease
By IPP Bureau - April 19, 2022
Through the association, Aster Volunteers would support 50 children from underprivileged families undergo liver transplants at Aster CMI and Aster RV Hospitals in Bangalore, and Aster Medcity and Aster MIMS Hospital Calicut in Kerala, India
Translumina launches Dual-Drug Polymer-free Coated Stent (DDCS)
By IPP Bureau - April 19, 2022
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Takeda announces approval of Nuvaxovid Covid-19 vaccine in Japan
By IPP Bureau - April 19, 2022
Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies
